Dr. Suleiman Alfred Massarweh MD Medical Oncologist

Dr. Suleiman Massarweh is a medical oncologist in Lexington, Kentucky and is affiliated with University of Kentucky Albert B. Chandler Hospital. He received his medical degree from University of Jordan Faculty of Medicine and has been in practice for 20 years. Dr. Massarweh accepts several types of health insurance, listed below. He is one of 2 doctors at University of Kentucky Albert B. Chandler Hospital who specialize in Medical Oncology. He also speaks multiple languages, including Arabic.

Are you Dr. Suleiman Massarweh? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology, Breast Cancer

Clinical Interests: Clinical trials, Neoplasm Metastasis, DNA Sequence Analysis, Neoplasm Drug Resistance, Breast Neoplasms, erbB-2 Receptor, Signal Transduction, Estrogen Receptors, Quinazolines, Nude Mice, Genomics

Hospital Affiliation

University of Kentucky Albert B. Chandler Hospital
High performing in Cancer

Education & Medical Training

Baylor College of Medicine
Residency, Internal Medicine, 1996 - 1999

Baylor College of Medicine
Fellowship, Medical Oncology, 1999 - 2002

University of Jordan Faculty of Medicine
Class of 1994

Certifications & Licensure

American Board of Internal Medicine
Certified 15 years in Internal Medicine

American Board of Internal Medicine
Certified 12 years in Hematology

American Board of Internal Medicine
Certified 12 years in Medical Oncology

American Board of Internal Medicine
Certified 4 years in Internal Medicine

American Board of Internal Medicine
Certified 2 years in Medical Oncology

KY State Medical License
Active through 2013

TX State Medical License
Active through 2013

Publications & Presentations

Inferring breast cancer concomitant diagnosis and comorbidities from the Nationwide Inpatient Sample using social network analysis
Radhakrishnan Nagarajan, Shengfan Zhang, Fay Cobb Payton, Suleiman Massarweh 2014 3 7

The Role of Ovarian Suppression in the Adjuvant Therapy of Premenopausal Women With ER-Positive Breast Cancer: A Commentary on the EBCTCG Overview Analysis
James Morgan, MD; Suleiman Massarweh, MD 2007 10

A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure.
Massarweh S, Romond E, Black EP, Van Meter E, Shelton B, Kadamyan-Melkumian V, Stevens M, Elledge R 2013 12 11

See all 28 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem Blue Access PPO
  • Anthem Blue Preferred HMO
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PPO
  • Sagamore Health Plus
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.